Maze Therapeutics, Inc. - MAZE
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors LP | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors GP LLC | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Senai Asefaw, M.D. | 0.0% | 0 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Paradigm BioCapital International Fund Ltd. | 0.0% | 0 | View |
| Jul 29, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.4% | 2,978,114 | View |
| May 15, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 5.8% | 2,858,876 | View |
| Apr 01, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors LP | 6.1% | 3,051,087 | View |
| Apr 01, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors GP LLC | 6.1% | 3,051,087 | View |
| Apr 01, 2026 | SCHEDULE 13G | Senai Asefaw, M.D. | 6.1% | 3,051,087 | View |
| Apr 01, 2026 | SCHEDULE 13G | Paradigm BioCapital International Fund Ltd. | 5.4% | 2,688,520 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.